These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33733040)

  • 21. Hymenoptera venom allergy.
    Przybilla B; Ruëff F
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sting challenge: indications and execution].
    Ruëff F; Przybilla B
    Hautarzt; 2014 Sep; 65(9):796-801. PubMed ID: 25234628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exclusive Bee Venom Allergy: Risk Factors and Outcome of Immunotherapy.
    Rosman Y; Nashef F; Cohen-Engler A; Meir-Shafrir K; Lachover-Roth I; Confino-Cohen R
    Int Arch Allergy Immunol; 2019; 180(2):128-134. PubMed ID: 31216540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab.
    Boni E; Incorvaia C; Mauro M
    Clin Mol Allergy; 2016; 14():14. PubMed ID: 27799850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal anaphylactic sting reaction in a patient with mastocytosis.
    Wagner N; Fritze D; Przybilla B; Hagedorn M; Ruëff F
    Int Arch Allergy Immunol; 2008; 146(2):162-3. PubMed ID: 18204283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venom immunotherapy in patients with allergic reactions to insect stings.
    Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
    Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
    Sahiner UM; Durham SR
    Front Immunol; 2019; 10():1959. PubMed ID: 31497015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Venom immunotherapy. Side effects and efficacy of treatment].
    Ruëff F; Przybilla B
    Hautarzt; 2008 Mar; 59(3):200-5. PubMed ID: 18264687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venom Immunotherapy: Questions and Controversies.
    Golden DBK
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):59-68. PubMed ID: 31761121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Follow-Up of Children after Venom Immunotherapy: Low Adherence to Anaphylaxis Guidelines.
    Fiedler C; Miehe U; Treudler R; Kiess W; Prenzel F
    Int Arch Allergy Immunol; 2017; 172(3):167-172. PubMed ID: 28380475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.
    Ruëff F; Vos B; Oude Elberink J; Bender A; Chatelain R; Dugas-Breit S; Horny HP; Küchenhoff H; Linhardt A; Mastnik S; Sotlar K; Stretz E; Vollrath R; Przybilla B; Flaig M
    Clin Exp Allergy; 2014; 44(5):736-46. PubMed ID: 24447114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unpredicted adverse reaction to omalizumab.
    Jandus P; Hausmann O; Haeberli G; Gentinetta T; Mueller U; Helbling A
    J Investig Allergol Clin Immunol; 2011; 21(7):563-6. PubMed ID: 22312942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
    Baenkler HW; Meusser-Storm S; Eger G
    Allergol Immunopathol (Madr); 2005; 33(1):7-14. PubMed ID: 15777517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New variants of diagnostic procedures and therapeutic methods in insect venom allergy].
    Nittner-Marszalska M
    Pol Merkur Lekarski; 2003 Jun; 14(84):700-2. PubMed ID: 14524309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients.
    Pospischil IM; Kagerer M; Cozzio A; Angelova-Fischer I; Guenova E; Ballmer-Weber B; Hoetzenecker W
    Int Arch Allergy Immunol; 2020; 181(10):783-789. PubMed ID: 32781451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy.
    Niedoszytko M; de Monchy J; van Doormaal JJ; Jassem E; Oude Elberink JN
    Allergy; 2009 Sep; 64(9):1237-45. PubMed ID: 19627278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New developments in the diagnosis and treatment of hymenoptera venom allergy.
    Müller UR
    Int Arch Allergy Immunol; 2001 Apr; 124(4):447-53. PubMed ID: 11340327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaphylaxis after hymenoptera sting: is it venom allergy, a clonal disorder, or both?
    Castells MC; Hornick JL; Akin C
    J Allergy Clin Immunol Pract; 2015; 3(3):350-5. PubMed ID: 25858055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.
    Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Aberer W; Birnbaum J; Bodzenta-Lukaszyk A; Bonifazi F; Bucher C; Campi P; Darsow U; Egger C; Haeberli G; Hawranek T; Kucharewicz I; Küchenhoff H; Lang R; Quercia O; Reider N; Severino M; Sticherling M; Sturm GJ; Wüthrich B;
    J Allergy Clin Immunol; 2010 Jul; 126(1):105-11.e5. PubMed ID: 20542320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on Insect Sting Anaphylaxis.
    Golden DBK
    Curr Allergy Asthma Rep; 2021 Mar; 21(3):16. PubMed ID: 33666774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.